Fennec Pharmaceuticals Inc

Officers & Directors

Fennec Pharmaceuticals Inc currently has 35 employees.

News about Fennec Pharmaceuticals Inc Key Personnel

Fennec Pharmaceuticals Appoints Industry Leader Jeffrey S. Hackman as CEO to Drive Commercial Success and Spearhead Oncology Innovations

Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
~ Accomplished Industry Leader Brings Extensive Commercialization and Oncology Expertise ~
Fennec Pharmaceuticals Inc, a leading biopharmaceutical company focused on the development of innovative oncology treatments, has recently announced the appointment of Jeffrey S. Hackman as its new Chief Executive Officer (CEO) and Director. With a strong track record in the pharmaceutical industry, Hackman s extensive commercialization and oncology expertise positions him well to lead Fennec Pharmaceuticals into its next phase of growth and success.
Hackman brings over 20 years of experience in the pharmaceutical in...

Business Description

Officers & Directors

FENC Management Effectiveness

FENC Revenue per Employee

FENC Income per Employee

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.